In patients with AML that have a NPM1 rearrangement, RPP30 is rearranged with NPM1 at exon 11, whereas the rearrangement of NPM1 with RPP30 is at the end of exon 9 (64). This evidence concerns the gene NPM1 and acute myeloid leukemia.